These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 33115863)
1. Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation. Conrady MC; Suarez I; Gogl G; Frecot DI; Bonhoure A; Kostmann C; Cousido-Siah A; Mitschler A; Lim J; Masson M; Iftner T; Stubenrauch F; Travé G; Simon C J Virol; 2020 Dec; 95(2):. PubMed ID: 33115863 [TBL] [Abstract][Full Text] [Related]
2. Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53. Martinez-Zapien D; Ruiz FX; Poirson J; Mitschler A; Ramirez J; Forster A; Cousido-Siah A; Masson M; Vande Pol S; Podjarny A; Travé G; Zanier K Nature; 2016 Jan; 529(7587):541-5. PubMed ID: 26789255 [TBL] [Abstract][Full Text] [Related]
3. Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides. Stutz C; Reinz E; Honegger A; Bulkescher J; Schweizer J; Zanier K; Travé G; Lohrey C; Hoppe-Seyler K; Hoppe-Seyler F PLoS One; 2015; 10(7):e0132339. PubMed ID: 26151636 [TBL] [Abstract][Full Text] [Related]
4. Multiple regions of E6AP (UBE3A) contribute to interaction with papillomavirus E6 proteins and the activation of ubiquitin ligase activity. Drews CM; Brimer N; Vande Pol SB PLoS Pathog; 2020 Jan; 16(1):e1008295. PubMed ID: 31971989 [TBL] [Abstract][Full Text] [Related]
5. The E6AP binding pocket of the HPV16 E6 oncoprotein provides a docking site for a small inhibitory peptide unrelated to E6AP, indicating druggability of E6. Zanier K; Stutz C; Kintscher S; Reinz E; Sehr P; Bulkescher J; Hoppe-Seyler K; Travé G; Hoppe-Seyler F PLoS One; 2014; 9(11):e112514. PubMed ID: 25383876 [TBL] [Abstract][Full Text] [Related]
6. Association of papillomavirus E6 proteins with either MAML1 or E6AP clusters E6 proteins by structure, function, and evolutionary relatedness. Brimer N; Drews CM; Vande Pol SB PLoS Pathog; 2017 Dec; 13(12):e1006781. PubMed ID: 29281732 [TBL] [Abstract][Full Text] [Related]
7. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6. Matsumoto Y; Nakagawa S; Yano T; Takizawa S; Nagasaka K; Nakagawa K; Minaguchi T; Wada O; Ooishi H; Matsumoto K; Yasugi T; Kanda T; Huibregtse JM; Taketani Y J Med Virol; 2006 Apr; 78(4):501-7. PubMed ID: 16482544 [TBL] [Abstract][Full Text] [Related]
8. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system. Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561 [TBL] [Abstract][Full Text] [Related]
9. Stepwise multipolyubiquitination of p53 by the E6AP-E6 ubiquitin ligase complex. Masuda Y; Saeki Y; Arai N; Kawai H; Kukimoto I; Tanaka K; Masutani C J Biol Chem; 2019 Oct; 294(41):14860-14875. PubMed ID: 31492752 [TBL] [Abstract][Full Text] [Related]
10. A ubiquitin variant-based affinity approach selectively identifies substrates of the ubiquitin ligase E6AP in complex with HPV-11 E6 or HPV-16 E6. Ebner FA; Sailer C; Eichbichler D; Jansen J; Sladewska-Marquardt A; Stengel F; Scheffner M J Biol Chem; 2020 Oct; 295(44):15070-15082. PubMed ID: 32855237 [TBL] [Abstract][Full Text] [Related]
11. Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53. Zanier K; ould M'hamed ould Sidi A; Boulade-Ladame C; Rybin V; Chappelle A; Atkinson A; Kieffer B; Travé G Structure; 2012 Apr; 20(4):604-17. PubMed ID: 22483108 [TBL] [Abstract][Full Text] [Related]
12. Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity. Thatte J; Banks L J Virol; 2017 Nov; 91(22):. PubMed ID: 28835500 [TBL] [Abstract][Full Text] [Related]
13. Structure based identification and characterization of flavonoids that disrupt human papillomavirus-16 E6 function. Cherry JJ; Rietz A; Malinkevich A; Liu Y; Xie M; Bartolowits M; Davisson VJ; Baleja JD; Androphy EJ PLoS One; 2013; 8(12):e84506. PubMed ID: 24376816 [TBL] [Abstract][Full Text] [Related]
14. HPV16 E6 confers p53-dependent and p53-independent phenotypes in the epidermis of mice deficient for E6AP. Shai A; Nguyen ML; Wagstaff J; Jiang YH; Lambert PF Oncogene; 2007 May; 26(23):3321-8. PubMed ID: 17130828 [TBL] [Abstract][Full Text] [Related]
15. Peptide interactions stabilize and restructure human papillomavirus type 16 E6 to interact with p53. Ansari T; Brimer N; Vande Pol SB J Virol; 2012 Oct; 86(20):11386-91. PubMed ID: 22896608 [TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase. Kao WH; Beaudenon SL; Talis AL; Huibregtse JM; Howley PM J Virol; 2000 Jul; 74(14):6408-17. PubMed ID: 10864652 [TBL] [Abstract][Full Text] [Related]
17. Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53. Cooper B; Schneider S; Bohl J; Jiang Yh; Beaudet A; Vande Pol S Virology; 2003 Feb; 306(1):87-99. PubMed ID: 12620801 [TBL] [Abstract][Full Text] [Related]
18. Felis catus papillomavirus type-2 E6 binds to E6AP, promotes E6AP/p53 binding and enhances p53 proteasomal degradation. Altamura G; Power K; Martano M; Degli Uberti B; Galiero G; De Luca G; Maiolino P; Borzacchiello G Sci Rep; 2018 Dec; 8(1):17529. PubMed ID: 30510267 [TBL] [Abstract][Full Text] [Related]
19. The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. Talis AL; Huibregtse JM; Howley PM J Biol Chem; 1998 Mar; 273(11):6439-45. PubMed ID: 9497376 [TBL] [Abstract][Full Text] [Related]